Memantine: Reality and Potentiality

Authors

  • Rita Moretti Department of Medicine and Neurology, University of Trieste, Trieste, Italy.
  • Paola Torre Department of Medicine and Neurology, University of Trieste, Trieste, Italy.
  • Cristina Vilotti Department of Medicine and Neurology, University of Trieste, Trieste, Italy.
  • Davide Manganaro Department of Medicine and Neurology, University of Trieste, Trieste, Italy.
  • Luca Zanet Department of Medicine and Neurology, University of Trieste, Trieste, Italy.
  • Rodolfo M. Antonello Department of Medicine and Neurology, University of Trieste, Trieste, Italy.

DOI:

https://doi.org/10.33393/dti.2008.1331

Keywords:

memantine, NMDA, glutamate, degeneration

Abstract

Memantine protects cultured neurons from excitotoxin-induced cell-death; it attenuated loss of cholinergic neurons in the CNS induced by injection of NMDA into the basal forebrain of rats. It has been shown that memantine induced production of brain-derived neurotrophic factor (BDNF), a substance shown to promote survival and differentiation of CNS neuron. Due to the preclinical effects of memantine owing to its anti-ischemic and anti-excitotoxic properties, recent clinical efficacy has been demonstrated in patients with advanced dementia of vascular origins. Therefore, it has been employed in different trials, in vascular dementia, showing a potential benefit and no unbearable side effects. Different studies underline the possible role of memantine in Parkinson Disease.

Downloads

Download data is not yet available.

Downloads

Published

2008-05-08

How to Cite

Moretti, R., Torre, P., Vilotti, C., Manganaro, D., Zanet, L., & Antonello, R. M. (2008). Memantine: Reality and Potentiality. Drug Target Insights, 3(1). https://doi.org/10.33393/dti.2008.1331

Metrics